Rozel Injection Denosumab 60 Mg

Rozel 60 mg Injection is a prescription medication containing the active ingredient denosumab, a monoclonal antibody used to treat osteoporosis and prevent bone complications in certain cancer patients. It is administered by a healthcare professional, typically once every six months for osteoporosis. Key Information

• Active Ingredient: Denosumab 60 mg/mL.
• Uses:
  • Treatment of osteoporosis in postmenopausal women and men at high risk of fractures.
  • Prevention of bone loss in men receiving hormone therapy for prostate cancer and women receiving therapy for breast cancer.
  • Management of bone metastases (cancer that has spread to the bones) and multiple myeloma.
  • Treatment of giant cell tumor of the bone.
• Administration: It is a subcutaneous injection administered by a doctor or nurse into the upper arm, thigh, or abdomen. It should not be self-administered.
• Dosage: The standard dose for osteoporosis is one 60 mg injection every 6 months.
• Storage: The injection should be stored in a refrigerator at 2-8°C (36-46°F) and not frozen.

Important Precautions & Side Effects

• Calcium and Vitamin D: Adequate calcium and vitamin D supplementation is crucial during treatment to prevent low blood calcium levels (hypocalcemia).
• Common Side Effects: Headache, musculoskeletal pain (bone, muscle, or joint pain), pain in extremities, constipation, and rash.
• Serious Side Effects: Rare but serious side effects can include osteonecrosis of the jaw (ONJ), atypical femoral fractures, and severe infections.
• Contraindications: Rozel should not be used during pregnancy or if you are allergic to denosumab. Women of childbearing potential must use effective birth control during and for at least 5 months after treatment.
• Medical History: Inform your doctor about your full medical history, especially kidney problems, liver issues, pre-existing hypocalcemia, or planned dental procedures.